New York, November 20 Researchers have identified a promising new strategy for glaucoma cell replacement therapy. Glaucoma is one of the leading causes of blindness worldwide, and vision loss, due to the loss of retinal ganglion cells (RGCs), cannot currently be reversed with any treatment. In the new study researchers at the Schepens Eye Research Institute of Mass Eye and …
Read More »